dacarbazine and Pituitary ACTH Hypersecretion

dacarbazine has been researched along with Pituitary ACTH Hypersecretion in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Kluczyński, Ł; Pach, D; Pantofliński, J; Sokołowski, G; Sowa-Staszczak, A; Turek-Jabrocka, R; Wilusz, M; Zieliński, G1
Bruce, JN; Carminucci, AS; Fine, RL; Gulati, AP; Lignelli, A; Remotti, H; Siegelin, M; Wardlaw, SL; Zacharia, BE1
Bruno, OD; Christiansen, SB; Danilowicz, K; Juárez-Allen, L1
Curtò, L; Trimarchi, F1
Denew, P; Kurowska, M; Maksymowicz, M; Malicka, J; Tarach, JS; Zieliński, G1
Fukuhara, N; Inoshita, N; Ohashi, K; Okuda, C; Oyama, K; Sano, T; Taguchi, M; Takeshita, A; Takeuchi, Y; Yamada, S1
Del Porto, L; Dobson, M; Maartens, NF1
Altavilla, G; Cannavò, S; Curtò, L; Ferraù, F; Granata, F; Hofland, LJ; Longo, M; Pitini, V; Torre, ML; Trimarchi, F1

Reviews

2 review(s) available for dacarbazine and Pituitary ACTH Hypersecretion

ArticleYear
Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
    Endokrynologia Polska, 2018, Volume: 69, Issue:3

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide

2018
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.
    TheScientificWorldJournal, 2010, Nov-04, Volume: 10

    Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Temozolomide; Treatment Outcome

2010

Other Studies

6 other study(ies) available for dacarbazine and Pituitary ACTH Hypersecretion

ArticleYear
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
    Neurosurgery, 2014, Volume: 74, Issue:4

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide

2014
Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease.
    Clinical endocrinology, 2015, Volume: 83, Issue:1

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary ACTH Hypersecretion; Remission Induction; Temozolomide; Treatment Outcome; Tumor Burden

2015
Authors' Reply to "Pituitary Atypical Adenoma or Carcinoma Sensitive to Temozolomide Combined with Radiation Therapy: A Case Report of Early Identification and Management".
    Turkish neurosurgery, 2015, Volume: 25, Issue:4

    Topics: Adenoma; Dacarbazine; Humans; Male; Pituitary ACTH Hypersecretion; Pituitary Neoplasms

2015
Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
    Endokrynologia Polska, 2016, Volume: 67, Issue:5

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Dacarbazine; Humans; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide; Treatment Outcome

2016
High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
    European journal of endocrinology, 2009, Volume: 161, Issue:4

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Hydrocortisone; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Temozolomide; Tomography, X-Ray Computed; Young Adult

2009
Comment on "Non-surgical treatment of hormone-secreting pituitary tumors".
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:9

    Topics: Adenoma; Clinical Trials as Topic; Dacarbazine; Humans; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Somatostatin; Temozolomide; Treatment Outcome

2010